Viewing Study NCT03275493

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2026-03-15 @ 1:50 AM
Study NCT ID: NCT03275493
Status: RECRUITING
Last Update Posted: 2024-05-28
First Post: 2017-09-05
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemia
Sponsor: Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Lymphoblastic Leukemia View
None CD19 Positive View
None Relapse View
None Refractory View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CD19+ ,CAR-T, CRS View